5 Key Takeaways

• 1

  Bracco Imaging is entering the cell therapy manufacturing market with a microbubble-based approach to replace magnetic beads.

• 2

  The microbubble technology aims to reduce cellular stress and eliminate residual materials in cell processing.

• 3

  Bracco's approach allows for both positive and negative selection strategies, enhancing immune cell subset isolation.

• 4

  The company is building a dedicated cell therapy team and collaborating with partners to develop automated selection systems.

• 5

  Bracco plans to manufacture the microbubble product at a new GMP-compliant facility in Geneva, targeting clinical use by 2027.